Related Articles
Determination of EGFR and KRAS mutational status in Greek non‑small‑cell lung cancer patients
Comparison of KRAS/BRAF mutations between primary tumors and serum in colorectal cancer: Biological and clinical implications
Application of PCR methods to evaluate EGFR, KRAS and BRAF mutations in a small number of tumor cells in cytological material from lung cancer patients
Serum peptide expression and treatment responses in patients with advanced non‑small‑cell lung cancer
Significance of epidermal growth factor receptor gene mutations in squamous cell lung carcinoma